期刊文献+

盐酸帕洛诺司琼治疗化疗后呕吐的临床研究

The clinical research on Palonosetron hydrochloride used to treat vomiting induced by chemotherapy
暂未订购
导出
摘要 目的:评价上海海天医药科技开发有限公司生产的盐酸帕洛诺司琼注射液(试验药物)防治化疗诱发恶心、呕吐的有效性与安全性。方法采用随机、双盲、自身交叉、阳性药对照研究设计,将入组患者随机分为AB周期(A周期为试验周期,分属于试验组;B周期为对照周期,分属于对照组。以下的BA周期与之相反)与BA周期,用相同的方案(含表阿霉素或顺铂)化疗2周期。AB周期化疗采用试验药物预防呕吐,BA周期用齐鲁制药有限公司生产的盐酸帕洛诺司琼注射液(对照药物)替代试验药物。NCICTCAE-3.0版方法评价受试者2周期化疗后第1-5日的恶心、呕吐、食欲以及全身情况。结果试验组和对照组各有17例病例可评价疗效,18例可评价安全性。2组药物治疗化疗后呕吐的总有效率均为100%;按照治疗全程呕吐、急性呕吐、迟发性呕吐分层,2组在完全缓解、部分缓解和轻微缓解方面均无差异;治疗恶心和食欲减退的疗效相近。不良反应轻微,主要为疲乏、便秘、头晕、头痛等。结论试验药物与对照药物在止吐疗效及毒性反应等方面均没有差异。 Objective To evaluate the effectiveness and security of Palonosetron Hydrochloride Injection (test drug) produced by Shanghai Haitian Pharmaceutical Corporation, which is used to prevention and cure nausea and vomiting that induced by chemotherapy.Methods A random, self-crossover, double blind and positive control drug experimental design was employed,patients was grouped into AB and BA by random, and received same chemotherapy scheme (contains epirubicin or cisplatin) 2 cycles. The group AB adopted test drug to prevent vomiting in the first chemotherapy cycle,and adopted Palonosetron Hydrochloride Injection produced by Qilu Pharmaceutical Corporation (comparison drug) as the replacement in the second. NCI-CTC AE 3.0 edition method was employed to evaluate the nausea, vomiting, anorexia, and physical condition of the participants in the first 1-5 days after 2 cycles' chemotherapy. Results In both treat group and comparison group, 17 cases could be evaluated in effectiveness and 18 eases in security. Both drug had a total effectiveness of 100% in treating chemotherapy's vomiting; if sorted by throughout vomiting, acute vomiting, and delayed vomiting, no difference existed between both group in complete alleviation, partial alleviation and slight alleviation; the effectiveness of treating nausea and anorexia were similar. Adverse reactions, including tired, constipation, giddy, headache etc. was slight. Conclusion No difference exists between both test drug and comparison drug in preventing vomiting and toxicity induced bY chemotheraov.
出处 《基层医学论坛》 2012年第16期2045-2047,共3页 The Medical Forum
关键词 盐酸帕洛诺司琼呕吐 恶心 化疗 临床研究 Palonosetron hydrochloride Vomit Nausea Chemotherapy Clinical research
  • 相关文献

参考文献10

  • 1张秋霞,赵公金.老年晚期胃癌应用不同化疗方案的疗效对比[J].中国实用医药,2009,4(28):9-10. 被引量:8
  • 2王海宁.帕洛诺司琼——长效止吐药[J].中国药房,2011,22(10):898-898. 被引量:2
  • 3黄雄.盐酸帕洛诺司琼、格拉司琼、昂丹司琼预防化疗呕吐的比较[J].贵阳医学院学报,2010,35(3):296-297. 被引量:20
  • 4Wasilewski A,Haller M.Effect of concord grape juice on chemotherapy-induced nausea and vomiting:results of a pilot study[J].Oncol Nurs Forum,2010,37(2):213-221.
  • 5Petru E,Andel J,Angleitner-Boubenizek L,et al.Early Austrian multicenter experience with palonosetron as antiemetic treatment for patients undergoing highly or moderately emetogenic chemotherapy[J].Wien Med Wochenschr,2008,158 (5-6):169-173.
  • 6Musso M,Scalone R,Bonanno V,et al.Palonosetron (Aloxi) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy[J].Support Care Cancer,2009,17(2):205-209.
  • 7Segawa.A phase Ⅱ dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy,including anthracycline and cyclophosphamide-based chemotherapy[J].Ann Oncol,2009,20(11):1874-1880.
  • 8Yu Z,Liu W,Wang L,et al.The efficacy and safety of palonosetron compared with granisetronin preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients:a Phase Ⅱ,multicenter,randomized,double blind,parallel,comparative clinical trial[J].Support Care Cancer,2009,17(1):99-102.
  • 9Massa E,Astara G,Madeddu C,et al.Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment:comparison between elderly and non-elderly patient response[J].Crit Rev Oncol Hematol,2009,70(1):83-91.
  • 10Giuliani F,Cilenti G.Palonosetron for prevention of acute and delayed nausea and vomiting induced by moderately metogenic adjuvant folfox-4 regimen in colorectal cancer (CRC) patients:A phase Ⅱ study of the Gruppo Oncologico dell'Italia Meridionale (GOIM)[J].European J Cancer,2008,6(14):102-106.

二级参考文献13

  • 1徐从高.癌-肿瘤学原理和实践.山东科学技术出版社,2002:1056.
  • 2Grazinao F, Catalano V, Baldelli AM, et al. A phase Ⅱ study of weekly doecstxle as salvage chemotherapy for advanced gastric cancr. Ann Onocl,2000,11 ( 10 ) : 1263-1266.
  • 3Murad AM, Petroianu A, Guimaraes RC, et al. Phase Ⅱ trial of the combination of paclitaxel and 5-fluorouracil in the treatment of advanced gastric cancer: a novel, safe, and effective regimen. Am J Clin Oncol, 1999,22 (6) :580-586.
  • 4Machover D, Goldschmidt E, Schwarzenberg L, et al. Treatment of advanced colorectal and gastric adenocarcinoma with 5-fluorouracil combined with high-dose folinic acid. Au Update. Chemioterapia, 1985,4(5) :369-376.
  • 5Sohn JH, Jeung HC, Shin H J, et al. Inlusinual floumuraeil, etoapside. and dsplatin(FEP) in advanced and relapsed gastric cancer. Am J Clin Onocl,2003,26(2) :203-209.
  • 6Piraccini G,Stolz R,Tei M,et al.Pharmacokinetic features of a novel 5-HT3-receptor antagonist:palonosetron (RS 25259-197)[J].Proc Am Soc Clin Oncol 2001(20):400a (Abstr 1595).
  • 7Macciocchi A,Gallagher S.A phase II dose-ranging study to assess single intravenous doses of palonosetron for the prevention of highly emetogenic chemotherapy-induced nausea and vomiting[J].Proc Am Soc Clin Oncol,2002(21):471a (Abstr 1480).
  • 8Gmlh R,Lichinitser M,Vegt SV,et al.Palonosetron improves prevention o f chemotherapy induced nausea and vomiting following moderately emetoge-nic chemotherapy:results of a double-blind randomized phaseⅢ trial comparing single doses of palono-setron with ondansetron[J].Ann of Oncol,2003(10):1570-l577.
  • 9Johnston D,Latreille J,Laberge F,et al.Preventing nausea and vomiting during days 2-7 following high dose cisplatin chemotherapy (HDCP).A study by the National Cancer Institute of Canada Clinical Trials Group (NCICCTG)[J].Proc Am Soc Clin Oncol,1995(14):529 (Abstr 1745).
  • 10Kaizer L,Warr D,Hoskins P,et al.Effet of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy:a phase III trial by the National Cancer Institute of Canada Clinical Trials Group[J].J Clin Oncol 1994(12):1050-1057.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部